scispace - formally typeset
I

I. Thomsen

Researcher at Aarhus University

Publications -  47
Citations -  763

I. Thomsen is an academic researcher from Aarhus University. The author has contributed to research in topics: Nitrile & Cycloaddition. The author has an hindex of 15, co-authored 47 publications receiving 741 citations.

Papers
More filters
Journal ArticleDOI

A Highly Diastereoselective and Enantioselective Ti(OTos)2−TADDOLate-Catalyzed 1,3-Dipolar Cycloaddition Reaction of Alkenes with Nitrones

TL;DR: In this article, a highly diastereo and enantioselective metal-catalyzed 1,3-dipolar cycloaddition reaction of 3-((E)-2'-alkenoyl)-1,3oxazolidin-2-ones with nitrones has been developed.
Journal ArticleDOI

Studies on organophosphorus compounds XLVII preparation of thiated synthons of amides, lactams and imides by use of some new p,s-containing reagents

TL;DR: The thionation properties of 2,4-bismethylthio-1,3,2,4dithiadiphosphetane 2, 4-disulfide, 1, 2-bis(4-phen-oxyphenyl)-1, 3,2-4-dithIaphosphetan is that 2, 3 and thionate most amides and lactams In THF at room temperature (reaction time 5 min) to give the corresponding thionated compounds as mentioned in this paper.
Journal ArticleDOI

Radical azidonation of aldehydes.

TL;DR: Aliphatic and aromatic aldehydes can be converted to acyl azides by treatment with iodine azide at 0-25 degrees C and the reaction was shown to have a radical mechanism.
Journal ArticleDOI

1-Azafagomine: A Hydroxyhexahydropyridazine That Potently Inhibits Enzymatic Glycoside Cleavage

TL;DR: Pyridazine 16 was found to be a potent inhibitor of α-and β-glucosidase, isomaltase and glyco-gen phosphorylase, while galactosidases and α-mannosid enzyme were not inhibited.
Journal ArticleDOI

Enantiospecific synthesis of 1-azafagomine.

TL;DR: For the first time the two enantiomeric forms of the glycosidase inhibitor 1-azafagomine have been synthesised starting from D- and L-xylose, finding the inhibition of almond beta-glucosidase by (-)-1 to be slow owing to a slow binding step of inhibitor to enzyme, with no subsequent conformational rearrangement.